Anemia due to iron kinetics and metabolism

Anemia Types:
- Explain the causes and effects of:
- Iron Deficiency Anemia (IDA)
- Anemia of Chronic Disease (ACD)
- Sideroblastic Anemia (SA)
- Hemochromatosis (iron overload).
Differentiation:
- Differentiate between IDA, ACD, SA, and iron overload using iron studies.
Bone Marrow and Peripheral Blood Findings:
- Compare bone marrow and peripheral blood findings of IDA, ACD, SA, and iron overload.
- Correlate findings in CBC report, bone marrow findings, and blood smear morphology.

Types of Anemia Studied:
- Iron Deficiency Anemia (IDA)
- Anemia of Chronic Diseases (ACD/ACI)
- Sideroblastic Anemia (SA)
- Hemochromatosis (iron overload)

Functionality:
- Essential for oxygen delivery throughout body tissues.
Regulation:
- There is no natural excretion mechanism for iron, thus its levels are carefully regulated.
Usage:
- Under normal circumstances, most iron is utilized for cellular processes.
Recycling:
- Iron is recycled within the body.
Absorption Rates:
- Approximately 1-2 mg of iron is absorbed daily, differing between men and women (MDR).

Process:
- Most iron is recycled through senescent red blood cells (RBCs):
- Ingested by macrophages in the spleen.
- Hemoglobin (HGB) is broken down and stored as ferritin, available for other cells (mainly erythroblasts) when necessary.
Supporting Proteins:
- Other plasma proteins, such as haptoglobin and hemopexin, facilitate iron salvage, which is further elaborated in Chapter 20 of Rodak’s Hematology Clinical Principles and Application (6th Edition).

Components:
- Iron enters through an enterocyte, circulates in blood to developing red blood cells, is influenced by hepcidin, and is involved in cellular iron acquisition and disposition.
- Key players include circulating RBCs, plasma transferrin (Tf), hepcidin, and splenic macrophages.

Utilization:
- Approximately 70% of the body’s iron is used for hemoglobin synthesis.
Storage:
- About 20% is stored in macrophages and hepatocytes.
Other Functions:
- Less than 1% is utilized for various other metabolic functions.

Entry Points:
- Iron in the lumen exists primarily as Fe3+.
- Conversion to Fe2+ occurs through dietary components, enabling absorption via:
- Dcytb (Dipeptidyl Peptidase 1)
- DMT1 (Divalent Metal Transporter 1)
- Iron absorption is facilitated further by heme transporters and ferroportin.
Transport:
- Transferrin (Tf) engages with iron for systemic circulation, with hepcidin regulating ferritin's uptake and release.

Components Involved:
- Liver, enterocytes, and macrophages play central roles in regulating iron levels via ferroportin.
Process:
- Elevated iron levels increase the absorption and release of iron while hepcidin functions to restrict ferroportin activity, thereby reducing iron transport out of cells.

Types of Iron Storage:
- Ferritin is the primary form of iron storage, being metabolically active and readily accessible.
- Hemosiderin is a less active, partially degraded form of ferritin found primarily in the liver and spleen, identified microscopically via Perl's Prussian Blue staining.

Key Measurements:
- Serum Iron (SI): Amount of circulating iron bound to plasma transferrin; it shows diurnal fluctuations, thus fasting samples are preferred.
- Total Iron Binding Capacity (TIBC): Reflects the maximum amount of iron binding that transferrin can handle; approximately 1/3 transferrin sites are saturated.
- Percent Transferrin Saturation (%SAT): Indicates the degree of occupancy of transferrin by iron; calculated as $ext{SI} / ext{TIBC} imes 100$ , with <16% indicating IDA.
- Prussian Blue Staining: Utilizes acidic potassium ferrocyanide as a reagent to detect tissue iron levels. This is the gold standard for assessing body iron but does not detect ferritin.
- Hemoglobin Content of Reticulocytes (HCR): Reflects iron availability for hemoglobin production; shows real-time measurements of iron levels in hemopoiesis.
- Soluble Transferrin Receptors (sTfR): Levels adjust based on intracellular iron levels; elevation indicates increased TfR due to iron deficiency or normal TfR in cases of accelerated erythropoiesis.
- Zinc Protoporphyrin (ZPP): Accumulates in RBCs when iron is not available for heme; increases indicate iron deficiency.

Causes of IDA:
- Inadequate iron intake, impaired absorption, chronic blood loss, and increased iron requirements not matched by absorption.

Stages of Iron Depletion:
- Stage 1: Storage iron depletion.
- Stage 2: Transport iron depletion.
- Stage 3: Functional iron depletion, culminating in IDA.

Suspicion of IDA:
- Presence of microcytic, hypochromic anemia and increased RDW.
- Other key findings include decreased MCV, MCH, MCHC, potential target cells, and early polychromasia (not always significant).

Findings:
- Decreased serum iron, decreased ferritin, increased TIBC, decreased transferrin saturation.
- Reticulocyte hemoglobin content is also decreased, indicating reduced iron availability.

Specific Evaluations:
- Increased Free Erythrocyte Protoporphyrin (FEP) and Zinc Protoporphyrin (ZPP).
- Bone marrow analysis shows no stainable iron with Perl's stain and moderate erythroid hyperplasia characterized by nuclear-cytoplasmic asynchrony.

Expected Outcomes:
- Reticulocyte hemoglobin content normalizes within 2 days, with reticulocyte counts increasing in 5-10 days.
- Hemoglobin levels increase within 2-3 weeks, returning to normal within 2 months, with microcytic/hypochromic features resolving over a few months.

Overview:
- ACD, often more appropriately termed anemia of chronic inflammation, is defined by sideropenia with deficiency in functional iron despite abundant stores.

Iron Studies Findings:
- Serum iron levels are decreased, while ferritin is increased or normal; TIBC is decreased with normal to decreased transferrin saturation and increased FEP/ZPP.
- Reticulocytes show decreased hemoglobin content, with soluble transferrin receptors normal.
Bone Marrow Studies:
- Not routinely required; typically shows hypo-proliferation of erythroblasts and abundant iron stores in macrophages without corresponding RBC precursors.

Characteristics:
- Increased ring sideroblasts in bone marrow, indicating iron deposits around mitochondria during hem synthesis.
- Serum iron and ferritin levels, %SAT, and FEP/ZPP show increases.
- Common cause includes lead poisoning, characterized by basophilic stippling.

Comparative Analysis:
- Result discrepancies between IDA, β-thalassemia, ACD, and sideroblastic anemia highlight different serum ferritin, serum iron, TIBC, transferrin saturation, FEP/ZPP levels, and bone marrow iron dynamics.

Mechanism:
- Iron overload occurs when the rate of iron acquisition exceeds the normal daily loss (approximately 1 mg/day).
- Genetic mutations of the HFE gene can lead to chronic iron retention.
- Acquired forms can result from repeated blood transfusions, particularly in patients with chronic anemias such as sickle cell anemia or β-thalassemia major.